Digistain Company

Digistain uses infrared scanning to determine which breast cancer patients are fit for chemotherapy.
Industry: Deep diagnostics
Headquarters: London, England, United Kingdom
Founded Date: 2020-01-01
Employees Number: 1-10
Funding Status: Seed
Total Funding: $125,000.00
Last Funding Type: Pre-Seed

Visit Website
contact@digistain.co.uk
Register and Claim Ownership